Cancer Medicines Forum: June 2023
EventHumanMedicines
Date
- Monday, 26 June 2023
Location
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
Event summary
The fifth Cancer Medicines Forum took place on the 26th June 2023 and reached an alignment on what treatment optimisation questions should be. The CMF is now expanding its activities in addressing the potential solutions and discussing the process of consultation of other stakeholders.
The European Cancer League presented its Access to Medicine task force, which focuses on access to affordable new drugs, potentially as well for drugs developed by academia. Emphasis is also placed on challenges for conducting non commercial clinical trials.
The CMF will address specific disease types where treatment optimisation should be prioritised. Methodological aspects and guidelines for designing treatment optimisation studies need to be further discussed as well as how optimisation studies can be linked to the regulatory framework for drug development and evaluation. The CMF aims to organise workshops to provide specific public communication on the CMF output.
The CMF aims to explore how EMA can contribute towards addressing remaining uncertainties about the use of cancer medicines in clinical practice.
The forum brings together representatives of academic organisations from EMA’s Healthcare Professionals Working Party and the European medicines regulatory network.
The results of discussions will support the prioritisation of actions to fight cancer in EMA's Regulatory Science Strategy to 2025 and Academia Collaboration Matrix Action Plan.
The meetings of the forum are by invitation only.